LianBio Additional Paid in Capital, Common Stock
LianBio (LIANY) had Additional Paid in Capital, Common Stock of $745.79 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2023-11-13
- 2023-09-30: Additional Paid in Capital, Common Stock $745.79M.
- 2023-06-30: Additional Paid in Capital, Common Stock $741.25M.
- 2023-03-31: Additional Paid in Capital, Common Stock $736.75M.
- 2022-12-31: Additional Paid in Capital, Common Stock $732.48M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2023-09-30 | $745.79M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $741.25M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $736.75M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $732.48M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $728.91M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $724.18M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $719.65M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $713.27M 10-K · filed 2023-03-28 |
| 2021-09-30 | $41.73M 10-Q/A · filed 2022-01-10 |
| 2020-12-31 | $31.13M 10-K · filed 2022-03-31 |